Inhibition of O-GlcNAcylation Reduces Cell Viability and Autophagy and Increases Sensitivity to Chemotherapeutic Temozolomide in Glioblastoma

SIMPLE SUMMARY: Glioblastoma (GB) is the most common and aggressive type of malignant brain tumor; however, despite advances in treatment modalities, it remains largely incurable. Current therapeutic protocols are ineffective, and temozolomide (TMZ), the main chemotherapy used in GB treatment, has a...

Descripción completa

Detalles Bibliográficos
Autores principales: Leonel, Amanda V., Alisson-Silva, Frederico, Santos, Ronan C. M., Silva-Aguiar, Rodrigo P., Gomes, Julia C., Longo, Gabriel M. C., Faria, Bruna M., Siqueira, Mariana S., Pereira, Miria G., Vasconcelos-dos-Santos, Andreia, Chiarini, Luciana B., Slawson, Chad, Caruso-Neves, Celso, Romão, Luciana, Travassos, Leonardo H., Carneiro, Katia, Todeschini, Adriane R., Dias, Wagner B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571858/
https://www.ncbi.nlm.nih.gov/pubmed/37835434
http://dx.doi.org/10.3390/cancers15194740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571858/
https://www.ncbi.nlm.nih.gov/pubmed/37835434
http://dx.doi.org/10.3390/cancers15194740

Ejemplares similares